PFE compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

PFEPfizer Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

PFEPfizer Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PFE

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±3.3%▲+1.52%×0.45

Q1 FY26±3.5%▲+0.57%×0.17

Feb 3 '26±3.2%▼−3.34%×1.03

Q3 FY25±4.2%▼−1.46%×0.36

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedPFE realized, solidLLY realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

PFEPfizer Inc

30.71▲+0.62%· post 31.03

Mkt cap$174.0BRevenue$15.0BQ2 FY26Revenue$62.6BFY25

LLYELI Lilly & Co

1,418.01▲+0.03%· post 1,412.00

ClosedNov 2 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 2 '26

PFEPfizer Inc

LLYELI Lilly & Co

30.71▲+0.62%post 31.03

Price

1,418.01▲+0.03%post 1,412.00

$174.0B

Mkt cap

$1.3T

Q2 FY26$15.0B

Revenue

$24.4BQ3 FY26

FY25$62.6B

Revenue

$65.2BFY25

PFE30.71▲+0.62%vsLLY1,418.01▲+0.03%ClosedNov 2 '26